Qubit Pharmaceuticals’ Post

Day 3 dawns with electric energy at #PharmaLytica2024, igniting new pathways and forging potent alliances. As we journey deeper into innovation and connectivity, #PharmaX illuminates boundless possibilities in pharma excellence. Let's spark brilliance together. Rahul Deshpande Jayesh Kanaskar Jatin Lad Sameer Matkar Dheeresh Bangera Mahesh Verma Ketki Karkhanis #PharmaX #PharmaLytica2024 #InformaMarketsIndia #Day3

Onset, performance and predictability of Cannabis products have long been the critical capstone of mass product adoption - their uncertainty a key barrier for consumers. With the completion of our #clinicalstudy on our proprietary nano emulsion technology - we are thrilled to see strong and substantiated performance markers: faster onset compared to traditional ingestible products, up to double the cannabinoid delivery at peak compared to the control group, and early indicators of a more predictable duration of the effect. Most importantly substantiated on-pack onset and bioavailability claims to educate the consumer about the product performance - launching in September. Very excited for the upcoming launch and also the pipeline of #cannabisinnovation that Organigram Inc will be able to commercialize leveraging this technology. #cannabisindustry #productdevelopment #innovation

🌟 Hannover Messe 2024 Recap Report Alert! 🌟 Hannover Messe 2024 was an electrifying showcase of the latest in digitization, automation, and electrification innovations, all aimed at achieving carbon neutrality and fostering high-performance solutions. From individual components to intelligent factories, the trade fair encompassed the entire industrial value chain. Curious about the insights gathered? Dive into our recap report meticulously crafted by Omdia analysts. Based on numerous conversations and meetings held at Hannover, this report delves into key themes including Artificial Intelligence, Digitalization, Industrial Sustainability, and the Circular Economy. Explore the report for invaluable takeaways on GenAI, Data Management, Ecosystem Development, and Software-Defined Automation. Have questions or comments? Reach out to me directly, and I can facilitate a follow-up discussion with our analysts. Let's navigate the future of industry together! #HannoverMesse2024 #IndustryInnovation #Digitization #Automation #OmdiaInsights

For anyone interested in establishing new collaborations in Japan, the webinar below may be interesting. I have been invited by EU-Japan Centre for Industrial Cooperation to share some interesting insights which will hopefully make it easier for you to navigate the wonderful (but complex) world of Japanese business culture, based on my experince at Selvita.

Recap: Here’s what we learned at Advanced Therapies Europe 2023 🧬 - The standstill of standardization 🐢 Discussions about process standardization in biotech aren't new, but their ongoing importance suggests a deep-rooted challenge in biotech. The progress over the last 10 years has been slower than many would have expected. - Crucial device and software integration of eBRs 💻 Electronic Batch Records are becoming a must-have in the current biotech landscape. However, to truly improve the efficiency in biopharma, the eBR platforms are not enough. They have to work together with other systems and devices. At MyCellHub we make a system that provides interoperability, and we were happy to ensure ATE participants of our easy device and software integration. - Financial dialogue shift 💰 Our ATE chats made us realize that in the last few years, ROI has been highly prioritized. Financial returns started to shape the initial consideration of digitalization, perhaps mirroring a tighter economic focus in biotech. 💬 Do you agree with our points? What were your takeaways from ATE? 💬 Big thanks to the organizers Phacilitate and everyone who stopped for a chat with us. 🙌 We're certain that changes are coming to the advanced therapies field and we’re looking forward to being part of its future. 🚀 #ate2023 #advancedtherapies #biopharma #biotech #celltherapy #genetherapy #digitalization

🚀 Elevating innovation in Biotech and MedTech! Dive into our latest blog where we explore the transformative power of strategic IP management with insights from De Clercq & Partners at the Solvay Advanced Master in Biotech & MedTech Ventures programme. Discover how mastering IP strategy can be your game-changer. 💡 Read the article: https://bit.ly/3xqmdkn #Innovation #IPStrategy #Biotech #MedTech #SolvayLifelongLearning

🔥 Unlock the secrets of strategic IP management with our latest article! 💡 Explore how De Clercq & Partners, in collaboration with Solvay Brussels School of Economics and Management, is revolutionizing innovation in Biotech & MedTech ventures. Don't miss out on this insightful read below. #Innovation #IPManagement #Biotech #MedTech #SolvayPartnership

The influx of unstructured data across life sciences presents a major challenge when it comes to managing the volume of adverse events. With 90% of biopharma and medtech expecting GenAI to impact their organizations within the year, many remain of wary of the risks. However, IQVIA’s Uwe Trinks argues that we cannot disregard emerging technologies simply on account of imperfection. Read more. https://bit.ly/3UQwbo5 #GenAI

NovaSterilis has been awarded a $1.75M grant by the NIH to advance emerging sterilization modalities for the biotech and pharma industries. Our supercritical carbon dioxide technology promises safer, more efficient sterilization methods, reducing reliance on harmful agents like ethylene oxide. Join us in exploring the future of scCO2 technology, shaping a safer, greener, and more efficient tomorrow. 🌱 Read the full press release: https://bit.ly/3T5OHqN #CelebrateScientistsDay

Dive into the Biotech Halftime Report to explore our outlook, including: 💡 Why innovation continues to be a hallmark of the biotech sector 💡 How manufacturing, safety, and treatment protocols can turn into setbacks 💡 What the unintended consequences of the Inflation Reduction Act may mean 💡 Whether M&A activity could pick up in the biotech space Get the summary: http://spr.ly/6041uzkcz